| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 304,450 | 410,124 | 160,948 | 1,138,856 | | Cost of Revenue | 254,138 | 19,534 | 96,116 |
-
| | | Gross Profit | 50,312 | 390,590 | 64,832 | 1,138,856 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,379 | 352,569 | 11,026 | 717,007 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 14,510 | 14,962 | 14,362 | 354,963 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (72,393) | 23,059 | 39,444 | 66,886 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (17,529) | | Earnings Before Interest And Taxes | 7,423 | 23,059 | 39,444 | 49,357 | | Interest Expense | 26,127 | 26,649 | 27,040 | 28,389 | | Income Before Tax | (18,704) | (3,590) | 12,404 | 20,968 | | Income Tax Expense | (400) | (273) | 563 | (101,893) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,304) | (3,317) | 11,841 | 122,861 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (18,304) | (3,317) | 11,841 | 122,861 | | Preferred Stock And Other Adjustments | (30,857) | (29,656) | (28,219) | (84,329) | | | Net Income Applicable To Common Shares | ($49,161) | ($32,973) | ($16,378) | $38,532 |
|
0.51% Nasdaq 
Income Statement
